Nanomedicine in Lung Cancer Immunotherapy
Lung cancer is the major cause of cancer death worldwide. Cancer immunotherapy has been introduced as a promising and effective treatment that can improve the immune system’s ability to eliminate cancer cells and help establish immunological memory. Nanoparticles can contribute to the rapidly evolvi...
Main Authors: | Mohammad Doroudian, Saba Zanganeh, Elham Abbasgholinejad, Seamas C. Donnelly |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1144653/full |
Similar Items
-
Smart Nanotherapeutics and Lung Cancer
by: Mohammad Doroudian, et al.
Published: (2021-11-01) -
Recent Advances of Microfluidic Platforms for Controlled Drug Delivery in Nanomedicine
by: Ejeta F
Published: (2021-09-01) -
Polysaccharide-based nanomedicines for cancer immunotherapy: A review
by: Yujun Zeng, et al.
Published: (2021-10-01) -
Advanced strategies for combinational immunotherapy of cancer based on polymeric nanomedicines
by: Kaisheng You, et al.
Published: (2024-06-01) -
Cancer immunotherapy and its facilitation by nanomedicine
by: Chao Sui, et al.
Published: (2024-08-01)